Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma

• Sakura Kirino,

  Roles Writing – original draft

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Kaoru Tsuchiya,

  Roles Resources, Writing – review & editing

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Masayuki Kurosaki,

  Roles Resources, Writing – review & editing

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Shun Kaneko,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  http://orcid.org/0000-0003-2660-6580

  ⨯
• Kento Inada,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Koji Yamashita,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Leona Osawa,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Yuka Hayakawa,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Shuhei Sekiguchi,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Mao Okada,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Wan Wang,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Mayu Higuchi,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Kenta Takaura,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Chiaki Maeyashiki,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Nobuharu Tamaki,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Yutaka Yasui,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Hiroyuki Nakanishi,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Jun Itakura,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Yuka Takahashi,

  Roles Resources

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  ⨯
• Yasuhiro Asahina,

  Roles Supervision

  Affiliations Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan, Department of Liver Disease Control, Tokyo Medical and Dental University, Tokyo, Japan

  ⨯
•  [ ... ],
• Namiki Izumi

  Roles Supervision, Writing – review & editing

  * E-mail: izumi012@musashino.jrc.or.jp

  Affiliation Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  http://orcid.org/0000-0002-0055-8229

  ⨯
• [ view all ]
• [ view less ]